PromarkerD Predicts Renal Function Decline in Type 2 Diabetes in the Canagliflozin Cardiovascular Assessment Study (CANVAS)

The ability of current tests to predict chronic kidney disease (CKD) complicating diabetes is limited. This study investigated the prognostic utility of a novel blood test, PromarkerD, for predicting future renal function decline in individuals with type 2 diabetes from the CANagliflozin CardioVascu...

Descripción completa

Detalles Bibliográficos
Autores principales: Peters, Kirsten E., Xu, Jialin, Bringans, Scott D., Davis, Wendy A., Davis, Timothy M.E., Hansen, Michael K., Lipscombe, Richard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600174/
https://www.ncbi.nlm.nih.gov/pubmed/33036174
http://dx.doi.org/10.3390/jcm9103212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600174/
https://www.ncbi.nlm.nih.gov/pubmed/33036174
http://dx.doi.org/10.3390/jcm9103212

Ejemplares similares